ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2163

Prevalence of Postoperative Anemia in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Undergoing Total Knee Arthroplasty: A Study of National Inpatient Sample 2010-2014

Karan Jatwani 1, Karan Chugh 2, Bikramjit Bindra 3 and Shraddha Jatwani2, 1Mount Sinai West - St Luke’s Hospital, New York, 2St. Vincent Evansville, Evansville, 3Government Medical College & Hospital, Chandigarh, India

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: psoriatic arthritis and anemia, Rheumatoid arthritis (RA), Total Knee Arthroplasty (TKA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Orthopedics, Low Back Pain, & Rehabilitation Poster – ACR/ARP

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Total knee arthroplasty (TKA) is a valuable option for improving function and pain control in patients with end-stage arthritis, especially those with inflammatory arthritis like Rheumatoid arthritis (RA) or Psoriatic arthritis (PsA). RA and PsA have been associated with an overall increased risk of peri-operative complications, including infections and cardiovascular mortality. There is limited information comparing short-term inpatient complications like post-operative anemia and wound dehiscence in patients with RA or PsA. Anemia has been associated with delayed functional recovery for patients undergoing arthroplasty as well as higher postoperative morbidity and mortality. We aim to assess the prevalence of short term inpatient complications like post-operative anemia and wound dehiscence in patients undergoing TKA with RA and PsA

Methods: National Inpatient Sample (NIS)is the largest all-payer inpatient care database in the United States, with approximately 8 million hospitalizations each year. We extracted data for all the adult admissions for TKA from NIS database from 2010-2014 and stratified it into groups based on the status of RA and PsA; using ICD-9 CM diagnostic codes. The baseline characteristics, mortality, the prevalence of post-operative infections, wound dehiscence, and postoperative acute hemorrhagic anemia were compared, using appropriate statistical tools. Stata version 15 (College Station, TX) was used to perform the statistical analysis.

Results: An estimated total of 3172824 hospitalizations for TKA were identified, with around 3157706 TKA and 15117 revision TKA. Amongst these hospitalizations 108101 had an underlying diagnosis of RA and 7421 had an underlying diagnosis of PsA. No difference in postoperative mortality, postoperative infections, or risk of wound dehiscence was noted in these subgroups. But these subgroups were found to have significantly higher rates (p< 0.05)of postoperative acute hemorrhagic anemia. The Odds Ratio for patients admitted for TKA with an underlying diagnosis of RA was estimated as 1.295(95% confidence interval=1.249-1.342). 27.92% hospitalizations for TKA with underlying RA were found to have post-operative anemia (p-value < 0.001). The admissions for TKA with psoriatic arthritis also had significantly higher odds of post-operative acute hemorrhagic anemia (Odds Ratio 1.13, 95% confidence interval 1.012-1.282).

Conclusion: The study estimates that admissions for TKA with underlying RA or PsA have significantly higher rates of postoperative anemia. It may represent pre-existing anemia worsening with surgery, as RA and PsA are associated with anemia of chronic disease. Another explanation can be concomitant use of medications like NSAIDs, DMARDs, or steroids for treatment of RA and PsA. We suggest that besides pre-operative cardiovascular and infection risk assessment, patients with RA and PsA should also be screened for anemia, to avoid postoperative morbidity and mortality.


TKA PsA RA Table 1

Table 1: Comparison of hospitalizations for TKA: National Inpatient Sample 2010-2014


Disclosure: K. Jatwani, None; K. Chugh, None; B. Bindra, None; S. Jatwani, None.

To cite this abstract in AMA style:

Jatwani K, Chugh K, Bindra B, Jatwani S. Prevalence of Postoperative Anemia in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Undergoing Total Knee Arthroplasty: A Study of National Inpatient Sample 2010-2014 [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/prevalence-of-postoperative-anemia-in-patients-with-rheumatoid-arthritis-and-psoriatic-arthritis-undergoing-total-knee-arthroplasty-a-study-of-national-inpatient-sample-2010-2014/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-of-postoperative-anemia-in-patients-with-rheumatoid-arthritis-and-psoriatic-arthritis-undergoing-total-knee-arthroplasty-a-study-of-national-inpatient-sample-2010-2014/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology